Research and Markets: US Epilepsy Market 2014-2019 - Market Analysis, Competitive Landscape & Drug Sales Forecasts

Business Wire


Research and Markets ( has announced the addition of the "US Epilepsy Market Highlights - 2014" report to their offering.

The latest research, 'US Epilepsy Market Highlights - 2014', provides the US epilepsy market analysis, competitive landscape, and epilepsy drug sales forecast in the US.

The research includes the US epilepsy market size estimates for 2013, market share forecast for six years to 2019, epilepsy drugs market share, epilepsy drugs sales estimates, epilepsy drugs sales forecast, and epilepsy late stage pipeline products.

This research helps executives track competitor drugs sales and market share in the US epilepsy market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US epilepsy market.


  • Identify drugs marketed in the US for treating epilepsy including trade name, molecule name, company, and year of launch.
  • Find out estimates for the US epilepsy market size in 2013, key products and their sales, and how the market and products advanced from 2010. You will benefit from our accurate country and indication level valuation of products and the market.
  • You will know the market share of leading epilepsy brands in the US, including generics share.
  • Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of epilepsy. Our coverage includes molecule, mechanism of action, and the originator.
  • Gain insights into how the US epilepsy market will advance along with market forecast till 2019. Determine future market events and trends including launch of new drugs and generic erosion of leading molecules.
  • Find out how epilepsy drugs will be positioned in the US in 2019, with drug sales forecast and drug market share analysis for both marketed products and pipeline products.

Key Topics Covered:

1. Epilepsy - Disease Definition

2. Marketed Epilepsy Drugs in US

3. US Epilepsy Market Analysis

4. Competitive Landscape in US Epilepsy Market

5. US Epilepsy Market - Future Market Outlook

For more information visit

Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals
View Comments (0)